What's Next for Berkshire Hathaway?
With CEO Warren Buffett, 93, headed for the end of his reign, questions are swirling about the company's future. The case for buying the stock now.
Barron'sApr 27 03:16 ET
Doctors Perform First Combined Heart Pump and Pig Kidney Transplant Surgery
Seeking AlphaApr 24 10:23 ET
Many Still Looking Away From DaVita Inc. (NYSE:DVA)
With a median price-to-earnings (or "P/E") ratio of close to 16x in the United States, you could be forgiven for feeling indifferent about DaVita Inc.'s (NYSE:DVA) P/E ratio of 16.8x. However, inves
Simply Wall StApr 23 12:59 ET
Garry Menzel Joins GHO Capital as Operating Partner
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR2 Therapeutics with significant investment and operating experience to support deal origination and provide best in class services to pioneering
GlobeNewswireApr 23 07:45 ET
Can DaVita Inc.'s (NYSE:DVA) ROE Continue To Surpass The Industry Average?
Yahoo FinanceApr 22 12:22 ET
DaVita's Global Operations Powered by 100% Renewable Energy
Kidney care provider enters virtual power purchase agreement in Spain after reaching 100% renewable energy goal in its North American operations DENVER, April 22, 2024 /PRNewswire/ -- By 2025, DaVita
DaVitaApr 22 00:00 ET
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
Yahoo FinanceApr 19 17:50 ET
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Yahoo FinanceApr 19 11:43 ET
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
Yahoo FinanceApr 19 11:14 ET
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo FinanceApr 18 18:00 ET
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
Yahoo FinanceApr 18 13:36 ET
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Yahoo FinanceApr 18 12:17 ET
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
Yahoo FinanceApr 17 13:00 ET
New Constituents of Goldman Sachs' ROE Growth Basket
Seeking AlphaApr 17 12:20 ET
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
DENVER, April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m.
DaVitaApr 17 00:00 ET
Barclays Keeps Their Hold Rating on DaVita (DVA)
TipRanksApr 15 04:26 ET
DaVita HealthCare (DVA) Stock Moves -0.75%: What You Should Know
The most recent trading session ended with DaVita HealthCare (DVA) standing at $130.42, reflecting a -0.75% shift from the previouse trading day's closing.
Yahoo FinanceApr 12 17:50 ET
Here's Why You Should Hold BD (BDX) Stock in Your Portfolio
Yahoo FinanceApr 12 11:04 ET
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Yahoo FinanceApr 12 11:00 ET
DaVita Welcomes New Board Member and Committee Participant
TipRanksApr 10 16:52 ET
No Data
No Data